Verily gets ECG approval for its study watch, Alphabet could bring the tech to Google wearables

Verily has received FDA clearance for the electrocardiogram feature on its study watch The health division of Google parent Alphabet says the watch can record and display single-channel ECG rhythms "Receiving this clearance showcases our commitment to the high standards of the FDA for safety and effectiveness and will help us advance the application of Study Watch in various disease areas and future indications," Verily said in a blog post.

The study watch from Verily is not a consumer device but now that it has received FDA approval, it will only be a matter of time before Google borrows the tech for its own wearable or the Wear OS platform The ECG approval for Verily study watch comes just days after Google announced that it has bought smartwatch tech for $40 million from Fossil Google's Wear OS platform lacks a device that can really challenge the Apple Watch in the smartwatch segment but the two announcements show the company is committed to the cause of wearables.

It seems Alphabet also wants a piece of this space and could launch Pixel Watch with updated interface and support for ECG function. . Source